Tecan and Enigma Diagnostics sign global manufacturing and supply agreement for point-of-care Molecular Diagnostics instruments
The Tecan Group and Enigma Diagnostics Limited announced the signing of a manufacturing and supply agreement for Enigma's ML instruments. Under the agreement, Tecan will industrialize and deliver commercially manufactured ML instruments for Enigma's global market supplies for an initial five-year contract and will also manage the ML instrument's supply chain. Financial details of the agreement were not disclosed.
John McKinley, Chairman and CEO of Enigma, said: "This is a milestone agreement for Enigma. We chose Tecan for its leading reputation as a developer and manufacturer of commercial medical instruments and its global range of technical and support services network. This represents the first of a number of potential additional agreements relating to Tecan's support of the Enigma ML system."
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Biovitrum and Symphogen have Successfully Completed Phase I Clinical Trial with Recombinant Polyclonal Antibody
Carbohydrate_metabolism
Category:Dutch_physiologists
Foix-Alajouanine_syndrome
Greig_cephalopolysyndactyly_syndrome
Geneva_Convention_(1929)

Sperm are masters of tetris packing - Hope for therapies against male infertility
Category:Animal_virology
Natural mother of pearl structure, synthetic replication
Ablynx and Algeta enter into collaboration to evaluate Thorium-277 conjugated to nanobodies
Bannayan-Zonana_syndrome
